Sternal osteomyelitis is classified as primary when there is no other focus of infection and secondary when it occurs as a complication of median sternotomy, chest trauma, mediastinitis or subclavian intravenous line insertion. Primary sternal osteomyelitis in infants is extremely rare. Only very few cases of primary sternal osteomyelitis in infants have been reported in the international literature. Of these, 5 children had sickle cell disease and the causative organism was Salmonella typhi[5].
Although sternal swelling is uncommon in children primary sternal osteomyelitis should be considered in the differential diagnosis.
As with osteomyelitis at other sites, plain radiographs are often normal initially becoming abnormal after 2 weeks [6]. However, our patient had significant radiological findings soon after the onset of symptoms, suggesting that the disease process may have commenced without obvious clinical signs. Ultrasound is helpful in defining soft tissue collections and periosteal involvement, and technetium bone scan may localize the disease and exclude other foci of infection. CT scan and MRI are both useful in delineating the extent of the bony destruction and retrosternal or mediastinal collections. MRI is considered to be superior to CT scan [7]. Computed tomography is also helpful to guide accurate biopsy for microbiological and histopathologic diagnosis. Bone scanning can also aid in the diagnosis of osteomyelitis and in some cases it may show changes earlier than X-rays [4].
Tissue biopsy is essential in order to exclude primary bone pathology and to obtain a microbiological isolate that will direct appropriate antimicrobial therapy. Indirect measures such as CRP, WBC, and antistaphylosin titers may assist the diagnosis [8]. Empiric antimicrobial therapy should cover Gram positive organisms and should be commenced once aspirate for cultures have been obtained. Antimicrobials may be rationalized once identification and sensitivities are known. In our case the infant was commenced with Vancomycin and Cefotaxime after swab cultures were obtained for 14 days and continued with Cefotaxime for 10 more days. After her discharge from the hospital the i.v. therapy was switched to 14 days of oral animicrobials (Cefuroxime axetil). The average antibiotic treatment time suggested by most authors for the management of acute osteomyelitis in children is two weeks by intravenous (i.v.) administration followed by additional outpatient oral therapy for periods of up to four weeks. This treatment regimen applied specifically to acute osteomyelitis led to no known treatment failures. However, recent studies suggest that shorter courses of parenetral antibiotic therapy do appear to influence response rates for children with acute haematogenous osteomyelitis [9]. Le Chaux et al., conducted a systematic review of a short versus long course of treatment for Acute Haematogenous Osteomyelitis due primarily to Staphylococcus aureus in children aged 3 months to 16 years. They searched Medline, Embase and the Cochrane trials registry for controlled trials. Clinical cure rate at 6 months was the primary outcome variable, and groups receiving less than seven days of intravenous therapy were compared with groups receiving one week or longer of intravenous antimicrobials. The overall cure rate at six months for the short course of intravenous therapy was 95.2% (95% CI = 90.4 - 97.7) compared to 98.8% (95% CI = 93.6, 99.8) for the longer course of therapy. There was no significant difference in the duration of oral therapy between the two groups. Given the potential increased morbidity and cost associated with longer courses of intravenous therapy, this finding should be confirmed through a randomized controlled equivalence trial [9].
The most common infecting organism in both primary and secondary sternal osteomyelitis is Staphylococcus aureus[3, 4, 10] and Pseudomonas aeruginosa is the most common infecting organism in intravenous drug abusers [3, 4, 11]. Mycobacterium tuberculosis in endemic areas [12], Aspergillus fumigatus in immunocompromised patients [13] and Candida albicans[14] have also been reported to cause sternal osteomyelitis. In our case report apart of Streptococcus pneumoniae, Enterococcus Species was also isolated, an organism that has never been reported before as an infecting cause of primary sternal osteomyelitis in the international literature. In all cases of primary sternal osteomyelitis, bacterial spread is likely to be haematogenous [2]. The extreme porous nature of the sternum with its extensive Volkman canals and Haversian system, together with few reticuloendothelial cells and abundant bone marrow, may make the sternum susceptible to primary osteomyelitis [5].
Surgical debridement is usually necessary in severe cases of primary sternal osteomyelitis although the role of surgery is much more clearly established in osteomyelitis secondary to sternotomy or in the debilitated patient [2]. Vacuum assisted suction drainage also has proved to be a useful adjunct to surgical debridement [15].
In conclusion, primary sternal osteomyelitis in infants and children is very rare. Sternal pain and swelling are usually but not invariably present and the usual peripheral markers of inflammation are often insensible. This can lead to delayed diagnosis and inappropriate initial treatment. If left untreated the condition can lead to mediastinitis, chronic osteomyelitis and chest wall deformity and instability [4]. If it is suspected on clinical grounds, antibiotic therapy should be given immediately before awaiting the results of any investigations [4]: antistaphylococcal medication is the therapy of choice until further results of culture and sensitivity tests become available [3, 10]. The optimal approach in uncomplicated cases may be a combination of aspiration for diagnostic purposes and prolonged antibiotic therapy. A patient's lack of response to antibiotic treatment or evidence of aggressive radiologic features are indications for surgery [3, 4]. Any sternal swelling should be fully investigated radiologically and preoperatively to exclude malignancy [3, 4]. Complete resolution should be expected [4].